A systematic review of income and education reporting in psychedelic clinical trials
- 12 May 2025
- journal article
- review article
- Published by Springer Nature in Nature Mental Health
- Vol. 3 (5) , 567-574
Abstract
Socioeconomic status (SES) substantially influences mental health outcomes and treatment access, yet its reporting in psychedelic-assisted therapy trials remains underexplored. Here we systematically reviewed 98 articles (49 primary trials and 49 secondary analyses) published between 2006 and 2024 examining classic psychedelics and MDMA for mental health conditions. Only 12% of primary trials reported participant income data, and 31% reported educational attainment. In US-based trials, participants showed markedly higher SES than the general population: 93% had some college education (versus 62% nationally), and median incomes in major trials substantially exceeded the national median for all workers. Non-US trials showed variable patterns. This widespread underreporting of SES data and evidence of socioeconomic disparities, particularly in US trials, highlights an urgent need for standardized SES reporting and targeted strategies to improve socioeconomic diversity in psychedelic-assisted therapy research, ensuring broader generalizability and access to these emerging treatments.Keywords
This publication has 65 references indexed in Scilit:
- Psychedelics in Addiction Treatment—Navigating a Sociopolitical RiftJAMA Neurology, 2024
- Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA, 2023
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use DisorderJAMA Psychiatry, 2022
- Demographic and Health Behavior Factors Associated With Clinical Trial Invitation and Participation in the United StatesJAMA Network Open, 2021
- Reporting of Participant Race, Sex, and Socioeconomic Status in Randomized Clinical Trials in General Medical Journals, 2015 vs 2019JAMA Network Open, 2021
- Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry, 2021
- Addressing Financial Barriers to Enrollment in Clinical TrialsJAMA Oncology, 2018
- Associations between socioeconomic status and psychological therapy outcomes: A systematic review and meta‐analysisDepression and Anxiety, 2018
- Associations Between Subjective Social Status andDSM-IVMental DisordersJAMA Psychiatry, 2014
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significancePsychopharmacology, 2006